Open access
Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices
Makoto Miyabayashi
M. Koshizaka
M. Shoji
Hiyori Kaneko
Kazuto Aono
Hisaya Kato
Tetta Sato
T. Horikoshi
M. Ishikawa
A. Sekiguchi
S. Motegi
S. Tsukamoto
A. Taniguchi
Y. Shoda
Toru Yoshimura
J. Kawashima
Kayo Yoshinaga
H. Nakagami
Y. Takami
Ken Sugimoto
Kunihiko Hashimoto
N. Okubo
Masato Ohara
Takashi Yoshida
Asako Kogure
Daisuke Suzuki
M. Kuzuya
Kazuhisa Watanabe
M. Takemoto
J. Oshima
Y. Maezawa
K. Yokote
Medicine
Abstract
This study compared metabolic dysfunction‐associated steatotic liver disease (MASLD) in individuals with Werner syndrome (WS) and individuals with insulin‐resistant type 2 diabetes (T2D). It also examined the association with imaging findings of MASLD in individuals with WS, clarified the characteristics of MASLD that accompany WS, and identified useful indices for its diagnosis in addition to imaging.